SEC Form 4 · accession 0001452429-26-000005
Century Therapeutics, Inc. · IPSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Truitt
Director
Period of report
Sep 9, 2026
Accepted (ET)
Sep 10, 2026 · 5:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001850119
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.03 | Sep 9, 2026 | A | 148,000 | A | — | Sep 9, 2036 | Common Stock | 148,000 | 148,000 | D |
Explanation of responses
- F1Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.